Search research articles
Contact Us
Filters
Showing results (41-50 of 149) with videos related to
Page
of 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 10, 2016
Confusion From the FDA on Compounding: Agency Tries to Expand List of Useable "Bulk Drug Substances"
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 12, 2017
Hospitals Press FCC to Expand Health Care on the Airwaves
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 18, 2016
Early Biosimilars Face Hurdles to Acceptance: The FDA Has Approved Few, So Lack of Competition Is Keeping Prices High
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 11, 2016
The White House Launches a Cancer Moonshot: Despite Funding Questions, the Progress Appears Promising
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
October 12, 2017
Off-Label Drug Bills Back on Track: But Democrats Could Run at Least One Off the Rails
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
October 12, 2017
More Clouds Form Over 340B Program: Potential Medicare Cut Underlines Need to Rein In Program
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
April 20, 2013
Hospitals worry about new FDA proposal for medical devices: technical complexities of labels could compromise utility
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
January 2, 2018
CMS Finalizes Drastic 340B Reimbursement Cut for 2018
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 3, 2017
Concerns Still Percolate Around Compounding: New FDA and GAO Reports Highlight Continuing Issues
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Bipartisan Drug-Patent Bills Ready for Senate Vote: Efforts Directed at Speeding Up Introduction of Generics
Stephen Barlas
Page
of 15
Search research articles
Search
Showing results (41-50 of 149) with videos related to
Sort By:
Page
of 15
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 10, 2016
Confusion From the FDA on Compounding: Agency Tries to Expand List of Useable "Bulk Drug Substances"
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 12, 2017
Hospitals Press FCC to Expand Health Care on the Airwaves
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 18, 2016
Early Biosimilars Face Hurdles to Acceptance: The FDA Has Approved Few, So Lack of Competition Is Keeping Prices High
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 11, 2016
The White House Launches a Cancer Moonshot: Despite Funding Questions, the Progress Appears Promising
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
October 12, 2017
Off-Label Drug Bills Back on Track: But Democrats Could Run at Least One Off the Rails
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
October 12, 2017
More Clouds Form Over 340B Program: Potential Medicare Cut Underlines Need to Rein In Program
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
April 20, 2013
Hospitals worry about new FDA proposal for medical devices: technical complexities of labels could compromise utility
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
January 2, 2018
CMS Finalizes Drastic 340B Reimbursement Cut for 2018
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
March 3, 2017
Concerns Still Percolate Around Compounding: New FDA and GAO Reports Highlight Continuing Issues
Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Bipartisan Drug-Patent Bills Ready for Senate Vote: Efforts Directed at Speeding Up Introduction of Generics
Stephen Barlas
Page
of 15